Cargando…

Investigation of allosteric coupling in human β(2)-adrenergic receptor in the presence of intracellular loop 3

BACKGROUND: This study investigates the allosteric coupling that exists between the intra- and extracellular parts of human β(2)-adrenergic receptor (β(2)-AR), in the presence of the intracellular loop 3 (ICL3), which is missing in all crystallographic experiments and most of the simulation studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozgur, Canan, Doruker, Pemra, Akten, E. Demet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930610/
https://www.ncbi.nlm.nih.gov/pubmed/27368374
http://dx.doi.org/10.1186/s12900-016-0061-9
_version_ 1782440770988408832
author Ozgur, Canan
Doruker, Pemra
Akten, E. Demet
author_facet Ozgur, Canan
Doruker, Pemra
Akten, E. Demet
author_sort Ozgur, Canan
collection PubMed
description BACKGROUND: This study investigates the allosteric coupling that exists between the intra- and extracellular parts of human β(2)-adrenergic receptor (β(2)-AR), in the presence of the intracellular loop 3 (ICL3), which is missing in all crystallographic experiments and most of the simulation studies reported so far. Our recent 1 μs long MD run has revealed a transition to the so-called very inactive state of the receptor, in which ICL3 packed under the G protein’s binding cavity and completely blocked its accessibility to G protein. Simultaneously, an outward tilt of transmembrane helix 5 (TM5) caused an expansion of the extracellular ligand-binding site. In the current study, we performed independent runs with a total duration of 4 μs to further investigate the very inactive state with packed ICL3 and the allosteric coupling event (three unrestrained runs and five runs with bond restraints at the ligand-binding site). RESULTS: In all three independent unrestrained runs (each 500 ns long), ICL3 preserved its initially packed/closed conformation within the studied time frame, suggesting an inhibition of the receptor’s activity. Specific bond restraints were later imposed between some key residues at the ligand-binding site, which have been experimentally determined to interact with the ligand. Restraining the binding site region to an open state facilitated ICL3 closure, whereas a relatively constrained/closed binding site hindered ICL3 packing. However, the reverse operation, i.e. opening of the packed ICL3, could not be realized by restraining the binding site region to a closed state. Thus, any attempt failed to free the ICL3 from its locked state due to the presence of persistent hydrogen bonds. CONCLUSIONS: Overall, our simulations indicated that starting with very inactive states, the receptor stayed almost irreversibly inhibited, which in turn decreased the overall mobility of the receptor. Bond restraints which represented the geometric restrictions caused by ligands of various sizes when bound at the ligand-binding site, induced the expected conformational changes in TM5, TM6 and consequently, ICL3. Still, once ICL3 was packed, the allosteric coupling became ineffective due to strong hydrogen bonds connecting ICL3 to the core of the receptor. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12900-016-0061-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4930610
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49306102016-07-03 Investigation of allosteric coupling in human β(2)-adrenergic receptor in the presence of intracellular loop 3 Ozgur, Canan Doruker, Pemra Akten, E. Demet BMC Struct Biol Research Article BACKGROUND: This study investigates the allosteric coupling that exists between the intra- and extracellular parts of human β(2)-adrenergic receptor (β(2)-AR), in the presence of the intracellular loop 3 (ICL3), which is missing in all crystallographic experiments and most of the simulation studies reported so far. Our recent 1 μs long MD run has revealed a transition to the so-called very inactive state of the receptor, in which ICL3 packed under the G protein’s binding cavity and completely blocked its accessibility to G protein. Simultaneously, an outward tilt of transmembrane helix 5 (TM5) caused an expansion of the extracellular ligand-binding site. In the current study, we performed independent runs with a total duration of 4 μs to further investigate the very inactive state with packed ICL3 and the allosteric coupling event (three unrestrained runs and five runs with bond restraints at the ligand-binding site). RESULTS: In all three independent unrestrained runs (each 500 ns long), ICL3 preserved its initially packed/closed conformation within the studied time frame, suggesting an inhibition of the receptor’s activity. Specific bond restraints were later imposed between some key residues at the ligand-binding site, which have been experimentally determined to interact with the ligand. Restraining the binding site region to an open state facilitated ICL3 closure, whereas a relatively constrained/closed binding site hindered ICL3 packing. However, the reverse operation, i.e. opening of the packed ICL3, could not be realized by restraining the binding site region to a closed state. Thus, any attempt failed to free the ICL3 from its locked state due to the presence of persistent hydrogen bonds. CONCLUSIONS: Overall, our simulations indicated that starting with very inactive states, the receptor stayed almost irreversibly inhibited, which in turn decreased the overall mobility of the receptor. Bond restraints which represented the geometric restrictions caused by ligands of various sizes when bound at the ligand-binding site, induced the expected conformational changes in TM5, TM6 and consequently, ICL3. Still, once ICL3 was packed, the allosteric coupling became ineffective due to strong hydrogen bonds connecting ICL3 to the core of the receptor. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12900-016-0061-9) contains supplementary material, which is available to authorized users. BioMed Central 2016-07-02 /pmc/articles/PMC4930610/ /pubmed/27368374 http://dx.doi.org/10.1186/s12900-016-0061-9 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Ozgur, Canan
Doruker, Pemra
Akten, E. Demet
Investigation of allosteric coupling in human β(2)-adrenergic receptor in the presence of intracellular loop 3
title Investigation of allosteric coupling in human β(2)-adrenergic receptor in the presence of intracellular loop 3
title_full Investigation of allosteric coupling in human β(2)-adrenergic receptor in the presence of intracellular loop 3
title_fullStr Investigation of allosteric coupling in human β(2)-adrenergic receptor in the presence of intracellular loop 3
title_full_unstemmed Investigation of allosteric coupling in human β(2)-adrenergic receptor in the presence of intracellular loop 3
title_short Investigation of allosteric coupling in human β(2)-adrenergic receptor in the presence of intracellular loop 3
title_sort investigation of allosteric coupling in human β(2)-adrenergic receptor in the presence of intracellular loop 3
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930610/
https://www.ncbi.nlm.nih.gov/pubmed/27368374
http://dx.doi.org/10.1186/s12900-016-0061-9
work_keys_str_mv AT ozgurcanan investigationofallostericcouplinginhumanb2adrenergicreceptorinthepresenceofintracellularloop3
AT dorukerpemra investigationofallostericcouplinginhumanb2adrenergicreceptorinthepresenceofintracellularloop3
AT aktenedemet investigationofallostericcouplinginhumanb2adrenergicreceptorinthepresenceofintracellularloop3